FINDINGS OF SCIENTIFIC MISCONDUCT

Release Date:  December 2, 1998

P.T.

Department of Health and Human Services

Notice is hereby given that the Office of Research Integrity (ORI) has made a
final finding of scientific misconduct in the following case:

Ms. Eileen Glennon, Harvard Medical School and Brigham and Women's Hospital: 
Based on a report submitted to the Office of Research Integrity (ORI) by the
Harvard Medical School (HMS) on June 30, 1998, as well as additional information
obtained by ORI during its oversight review, ORI found that Ms. Glennon, former
research technician, Endocrine-Hypertension Division, Brigham and Women's
Hospital (BWH), engaged in scientific misconduct arising out of certain
biomedical research supported by a grant from the National Heart, Lung, and Blood
Institute (NHLBI), National Institutes of Health (NIH), and a grant from the
National Center for Research Resources (NCRR), NIH.

Specifically, Ms. Glennon fabricated data to plot standard curves while
conducting radioimmunoassays to determine angiotensin II concentrations.  When
the assays appeared not to be working, which occurred in approximately half of
the assays over a one year period, she used numbers from previous standard curves
and then used the fabricated standard curve to determine the concentration of
angiotensin II, thus producing false experimental results.

Ms. Glennon cooperated fully with the institutional inquiry panel and admitted
her acts.

Ms. Glennon has accepted the ORI finding and has entered into a Voluntary
Exclusion Agreement with ORI in which she has voluntarily agreed, for the three
year period beginning November 13, 1998:

(1) to exclude herself from serving in any advisory capacity to the Public Health
Service (PHS), including but not limited to service on any PHS advisory
committee, board, and/or peer review committee, or as a consultant; and

(2) that any institution that submits an application for PHS support for a
research project on which her participation is proposed or which uses her in any
capacity on PHS supported research, or that submits a report of PHS-funded
research in which she is involved, must concurrently submit a plan for
supervision of her duties to the funding agency for approval.  The supervisory
plan must be designed to ensure the scientific integrity of Ms. Glennon's
research contribution.  The institution also must submit a copy of the
supervisory plan to ORI.

INQUIRIES

For further information contact:

Acting Director
Division of Research Investigations
Office of Research Integrity
5515 Security Lane, Suite 700
Rockville, MD  20852
Telephone:  (301) 443-5330

Return to Volume Index

Return to NIH Guide Main Index

	Office of Extramural Research (OER)			National Institutes of Health (NIH) 9000 Rockville Pike Bethesda, Maryland 20892			Department of Health and Human Services (HHS)